Gapping up
In reaction to strong earnings/guidance:
- TER +14.6%, UMC +11.7%, EW +11.5%, SNAP +10%, CSTM +8.2%, MANH +7.1%, TRVG +6.6%, TXN +5.8%, VFC +3.7%, UPS +3.3%, CMG +3%, CSL +2.6%, CNI +2.5%, FLIR +2.4%, NAVI +2.2%, RHI +2.2%, ALXN +2.1%, DFS +1.8%, RNR +1%, SPN +0.9%, SIX +0.9%
Select semiconductor stocks trading higher:
- ADI +2.6%, NXPI +2%, ON +1.5%, MXIM +1.3%, SOXX +0.9%, SMH +0.8%, MU +0.5%
Other news:
- JNCE +27.1% (Jounce Therapeutics provides update on strategic collaboration with Celgene [CELG] -- Celgene has licensed worldwide rights to JTX-8064)
- ITCI +12.5% (provides FDA Advisory update; may result in extension of PDUFA target date),
- THC +7.9% (to pursue a tax-free spin-off of its Conifer business as a separate, independent publicly traded company)
- GHDX +7.5% (to join S&P SmallCap 600, effective prior to the open on July 29)
- OLBK +4.5% (Old Line Bancshares merging with WesBanco (WSBC)
- OLBK to receive 0.7844 shares of WSBC, valuing the company at $500 mln, or $29.56/share)
- WFC +0.6% (confirms increase of quarterly common stock dividend to $0.51/share from $0.45/share and increases common stock repurchase authority by an additional 350 mln shares)
- CELG +0.5% (Jounce Therapeutics provides update on strategic collaboration with Celgene -- Celgene has licensed worldwide rights to JTX-8064)
Analyst comments:
- MPW +3.7% (upgraded to Buy from Hold at Stifel)
- CE +1% (upgraded to Overweight from Neutral at JP Morgan)